Curran Simpson sold $263k of RGNX
Chief Executive Officer at REGENXBIO Inc.. 20,811 shares at an average of $12.62, traded Oct 9, 2025, filed Oct 10, 2025.
Score components
- +25RoleCEO
- +13Trade size$263k at market
- 0Share of holdings soldSold 8.8% of holdings
- 0ClusterNo other insider selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m +2.7%, 3m +33.6%, 6m -19.4%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001346164-25-000005, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Oct 9, 2025 | SOpen-market sale Common Stock10b5-1 | -20,811 | $12.62 | $263k | 216,162 | Oct 10, 2025 |
Related signals
Other insiders at REGENXBIO Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 57Moderate | RGNXbuy REGENXBIO Inc. | Gregory Austin Ciongoli director | $949k 102,603 shares | +665% | |
| 0Weak | REGENXBIO Inc. | Steve Pakola Chief Medical Officer | $29k 2,161 shares | -1% | |
| 6Weak | REGENXBIO Inc. | Steve Pakola Chief Medical Officer | $689k 56,333 shares | -24% | |
| 6Weak | REGENXBIO Inc. | Steve Pakola Chief Medical Officer | $169k 15,309 shares | -6% | |
| 2Weak | REGENXBIO Inc. | Steve Pakola Chief Medical Officer | $53k 5,124 shares | -2% | |
| 13Weak | REGENXBIO Inc. | Curran Simpson Chief Executive Officer | $76k 7,624 shares | -3% | |
| 13Weak | REGENXBIO Inc. | Curran Simpson Chief Executive Officer | $77k 7,734 shares | -3% | |
| 0Weak | REGENXBIO Inc. | Kenneth T. Mills President and CEO | $163k 20,602 shares | -4% | |
| 18Weak | REGENXBIO Inc. | Kenneth T. Mills President and CEO | $886k 45,000 shares | -11% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.